Brazilian cancer centers test new biosimilar treatment
Disease control
Recruiting now
This study is observing how well a biosimilar version of the drug bevacizumab works for people in Brazil with advanced colorectal cancer that has spread and cannot be removed by surgery. Researchers will follow 133 patients who are already receiving this drug as part of their sta…
Sponsor: Libbs Farmacêutica LTDA • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC